Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BY 4.0Nutrients

Serum Copper-to-Zinc and Copper-to-Selenium Ratios in Inflammatory Bowel Disease: Possible Associations with Clinical Disease Activity and Endoscopic Healing in a Cross-Sectional Study with Prospective Enrollment

  • Chao-Feng Chang1,2
  • Yi-Chiao Cheng3,4
  • Chang-Hung Liao1,2
  • Puo-Hsien Le2,3,5
  • Tien-Yu Huang1,2,3
5 affiliations
  1. 1Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan
  2. 2Taiwan Association for the Study of Intestinal Diseases, Taoyuan 333, Taiwan
  3. 3Taiwan Society of Inflammatory Bowel Disease, Taipei 100, Taiwan
  4. 4Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan
  5. 5Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 333, Taiwan
Open at sourceDOICite

Abstract

Background/Objectives: The associations of serum copper-to-zinc (Cu/Zn) and copper-to-selenium (Cu/Se) ratios with clinical disease activity and endoscopic healing in inflammatory bowel disease (IBD) remain incompletely characterized. Although trace element imbalances have been linked to intestinal inflammation, the clinical utility of composite trace element ratios remains unclear. We investigated whether serum copper-to-zinc (Cu/Zn) and copper-to-selenium (Cu/Se) ratios reflect clinical disease activity and mucosal status in IBD. Methods: This cross-sectional study with prospective enrollment recruited patients with IBD and non-IBD controls between July 2023 and October 2024. Serum Cu, Zn, and Se concentrations were measured to calculate Cu/Zn and Cu/Se ratios. Clinical disease activity was assessed using the Crohn’s Disease Activity Index (CDAI) and partial Mayo score. Endoscopic healing was defined as the absence of ulcers or erosions on endoscopy within 3 months of enrollment. Results: Among 190 participants, 62 had Crohn’s disease (CD), 69 had ulcerative colitis (UC), and 59 were non-IBD controls. Cu/Zn and Cu/Se ratios differed across controls and clinical activity categories (both overall p = 0.001), with the highest mean values in patients with moderate-to-severe activity. In the overall IBD cohort, AUC values for distinguishing moderate-to-severe activity from remission or mild activity were 0.749 and 0.736 for Cu/Zn and Cu/Se, respectively. Both ratios remained higher in patients with moderate-to-severe activity than in controls after adjustment for age, sex, and BMI (both p < 0.001). In CD, both ratios correlated positively with CDAI (Cu/Zn: rho = 0.500; Cu/Se: rho = 0.498; both p < 0.001). Cu/Zn and Cu/Se ratios differed across controls and patients with and without endoscopic healing (overall p < 0.001 and p = 0.003, respectively); however, the Cu/Zn difference between the two patient groups was not statistically significant. Conclusions: Serum Cu/Zn and Cu/Se ratios were associated with clinical disease activity, but their utility for assessing endoscopic healing and their incremental value beyond established biomarkers remain uncertain. Longitudinal validation is needed before routine clinical use can be supported.

Related

  1. Atrial Septal Aneurysm and Anxiety: A Matched Cross-Sectional Study with Prospective Enrollment Exploring Clinical and Psychosomatic Associations
    Doğaç Çağlar Gürbüz, Hasan Atmaca, Hicran Damar +2
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  2. Beyond BMI: Associations of Body-Shape Indices with CBC-Derived Systemic Inflammatory Indices in Adults with Metabolic Syndrome: A Cross-Sectional Study
    Kamil Konur, Erol Karavar, Oğuzhan Kesen +2
    MetabolitesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  3. Associations Between Absolute Eosinophil and Basophil Counts and Systemic Immune-Inflammatory Indices in Lung Cancer Patients: A Cross-Sectional Observational Study.
    Olivian Savencu, Horia Liscu, Nicolae I Verga
    CureusPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  4. Efficiency of a Multi-step Screening and Enrichment Process for Prospective Sepsis Cohort Enrollment
    L. A. Cosimi, W. Qi, S. Naz-McLean +11
    medRxivPreprintCC BY-NCFull textInfectious diseasemedRxiv
  5. Safety and Recovery Profile of Propofol-Based Intravenous Sedation for Endoscopic Retrograde Cholangiopancreatography in Adults: A Prospective Single-Center Observational Study
    Muhammad Ahmad Khan, Tariq Mahmood, Mirza Ahmad Raza Baig +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{chang2026serum,
  title = {{Serum Copper-to-Zinc and Copper-to-Selenium Ratios in Inflammatory Bowel Disease: Possible Associations with Clinical Disease Activity and Endoscopic Healing in a Cross-Sectional Study with Prospective Enrollment}},
  author = {Chao-Feng Chang and Yi-Chiao Cheng and Chang-Hung Liao and Puo-Hsien Le and Tien-Yu Huang},
  journal = {Nutrients},
  year = {2026},
  month = oct,
  doi = {10.3390/nu18213593},
  url = {https://www.mdpi.com/2072-6643/18/21/3593},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Serum Copper-to-Zinc and Copper-to-Selenium Ratios in Inflammatory Bowel Disease: Possible Associations with Clinical Disease Activity and Endoscopic Healing in a Cross-Sectional Study with Prospective Enrollment
AU  - Chao-Feng Chang
AU  - Yi-Chiao Cheng
AU  - Chang-Hung Liao
AU  - Puo-Hsien Le
AU  - Tien-Yu Huang
PY  - 2026
DA  - 2026/10/29
JO  - Nutrients
DO  - 10.3390/nu18213593
UR  - https://www.mdpi.com/2072-6643/18/21/3593
AB  - Background/Objectives: The associations of serum copper-to-zinc (Cu/Zn) and copper-to-selenium (Cu/Se) ratios with clinical disease activity and endoscopic healing in inflammatory bowel disease (IBD) remain incompletely characterized. Although trace element imbalances have been linked to intestinal inflammation, the clinical utility of composite trace element ratios remains unclear. We investigated whether serum copper-to-zinc (Cu/Zn) and copper-to-selenium (Cu/Se) ratios reflect clinical disease activity and mucosal status in IBD. Methods: This cross-sectional study with prospective enrollment recruited patients with IBD and non-IBD controls between July 2023 and October 2024. Serum Cu, Zn, and Se concentrations were measured to calculate Cu/Zn and Cu/Se ratios. Clinical disease activity was assessed using the Crohn’s Disease Activity Index (CDAI) and partial Mayo score. Endoscopic healing was defined as the absence of ulcers or erosions on endoscopy within 3 months of enrollment. Results: Among 190 participants, 62 had Crohn’s disease (CD), 69 had ulcerative colitis (UC), and 59 were non-IBD controls. Cu/Zn and Cu/Se ratios differed across controls and clinical activity categories (both overall p = 0.001), with the highest mean values in patients with moderate-to-severe activity. In the overall IBD cohort, AUC values for distinguishing moderate-to-severe activity from remission or mild activity were 0.749 and 0.736 for Cu/Zn and Cu/Se, respectively. Both ratios remained higher in patients with moderate-to-severe activity than in controls after adjustment for age, sex, and BMI (both p < 0.001). In CD, both ratios correlated positively with CDAI (Cu/Zn: rho = 0.500; Cu/Se: rho = 0.498; both p < 0.001). Cu/Zn and Cu/Se ratios differed across controls and patients with and without endoscopic healing (overall p < 0.001 and p = 0.003, respectively); however, the Cu/Zn difference between the two patient groups was not statistically significant. Conclusions: Serum Cu/Zn and Cu/Se ratios were associated with clinical disease activity, but their utility for assessing endoscopic healing and their incremental value beyond established biomarkers remain uncertain. Longitudinal validation is needed before routine clinical use can be supported.
SN  - 2072-6643
ER  -